Amgen D.C. office
Two more former Pharmaceutical Research & Manufacturers of America staffers have joined Amgen's Washington, D.C. office: Helen Rhee and Thomas Moore. Both will be reunited with former PhRMA Senior VP Rodger Currie, who joined Amgen in May, as well as several other former members of PhRMA's lobbying team (1"The Pink Sheet" April 5, 2004, p. 9)...
You may also be interested in...
Governor Cuomo will establish two panels, one examining safety and efficacy and another considering distribution and pricing, to advise the state on how to approach use of coronavirus vaccines once one is approved.
Chief medical officer Samit Hirawat outlines R&D successes – though there have been some setbacks since it bought Celgene for $74bn last year – and the company’s commitment to clinical trial diversity.
Letter from department’s general counsel responds to request from the company for a pre-enforcement advisory opinion. Despite the letter, Lilly maintains its ‘limited distribution program is fully consistent with applicable laws and regulations.’